EAM
GILD icon

Empirical Asset Management’s Gilead Sciences GILD Stock Holding History

Empirical Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
11,184
-603
-5% -$84.4K 0.41% 58
2025
Q4 		$1.45M Buy
11,787
+3,279
+39% +$398K 0.41% 64
2025
Q3 		$944K Sell
8,508
-662
-7% -$75.2K 0.26% 101
2025
Q2 		$1.02M Buy
9,170
+1,882
+26% +$200K 0.31% 85
2025
Q1 		$817K Buy
7,288
+240
+3% +$24.8K 0.28% 97
2024
Q4 		$651K Hold
7,048
– – 0.22% 132
2024
Q3 		$591K Hold
7,048
– – 0.21% 146
2024
Q2 		$484K Sell
7,048
-10,129
-59% -$676K 0.18% 164
2024
Q1 		$1.26M Buy
17,177
+3,581
+26% +$275K 0.61% 39
2023
Q4 		$1.1M Sell
13,596
-8,747
-39% -$681K 0.9% 28
2023
Q3 		$1.67M Buy
22,343
+799
+4% +$61.5K 1.46% 9
2023
Q2 		$1.66M Buy
21,544
+537
+3% +$42.8K 1.47% 11
2023
Q1 		$1.74M Buy
21,007
+7,412
+55% +$614K 1.67% 9
2022
Q4 		$1.17M Sell
13,595
-9,201
-40% -$729K 1.23% 16
2022
Q3 		$1.41M Buy
22,796
+8,679
+61% +$547K 1.53% 11
2022
Q2 		$873K Buy
14,117
+524
+4% +$32.4K 0.92% 29
2022
Q1 		$808K Buy
+13,593
New +$869K 0.77% 42

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Empirical Asset Management's GILD Position: Q1 2026 in Review

Empirical Asset Management reduced its Gilead Sciences (GILD) stake by 5.1% in Q1 2026, selling an estimated $84.4K and leaving 11,184 shares worth $1.56M. The position accounts for 0.41% of the portfolio, ranked #58.

Empirical Asset Management first reported a position in GILD in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.74M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Empirical Asset Management held 11,184 shares of Gilead Sciences worth $1.56M as of Q1 2026.
  • Empirical Asset Management sold 603 Gilead Sciences shares in Q1 2026, an estimated $84.4K.
  • Gilead Sciences made up 0.41% of Empirical Asset Management's portfolio in Q1 2026, its #58 holding.
  • Empirical Asset Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 17 quarters since.
  • Empirical Asset Management's Gilead Sciences position peaked at $1.74M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Empirical Asset Management's 13F filing for Q1 2026, filed 11 May 2026.